Sintx Technologies (NASDAQ:SINT) Price Target Raised to $12.50

Sintx Technologies (NASDAQ:SINT) had its price objective boosted by Ascendiant Capital Markets from $12.00 to $12.50 in a research report report published on Thursday,Benzinga reports. Ascendiant Capital Markets currently has a buy rating on the stock.

A number of other brokerages have also commented on SINT. Weiss Ratings restated a “sell (e+)” rating on shares of Sintx Technologies in a research note on Friday, July 17th. Maxim Group reiterated a “buy” rating and set a $6.00 price target on shares of Sintx Technologies in a research note on Thursday, June 4th. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $9.50.

Sintx Technologies Stock Performance

Shares of SINT opened at $2.21 on Thursday. The stock’s 50-day moving average price is $1.70 and its 200 day moving average price is $2.04. Sintx Technologies has a 12-month low of $1.40 and a 12-month high of $4.64.

Sintx Technologies (NASDAQ:SINT) last announced its quarterly earnings data on Tuesday, August 11th. The company reported ($0.75) EPS for the quarter, missing analysts’ consensus estimates of ($0.73) by ($0.02). Sintx Technologies had a negative return on equity of 354.44% and a negative net margin of 848.20%.The firm had revenue of $0.45 million during the quarter, compared to the consensus estimate of $0.46 million. Equities analysts predict that Sintx Technologies will post -1.67 EPS for the current year.

About Sintx Technologies

SINTX Technologies, Inc is an advanced materials company that develops and manufactures silicon nitride-based ceramics. Its technology is designed to provide properties such as high strength, wear resistance, biocompatibility and antimicrobial performance, supporting applications in healthcare and other demanding industries.

The company’s medical activities have focused on ceramic components and implantable products for orthopedic and spinal procedures, including technologies used in spinal fusion and other reconstructive applications.